Founded in 2019, JLS Fund is a unique venture capital fund focused primarily on neuroscience, mental health and enabling tools and infrastructure. From Pre-seed and Seed investing to Series A and later-stage secondaries transitioning to buyout.
Mental health company dedicated to providing access to safe and affordable psychedelic-assisted therapy, beginning with ketamine therapy.
A clinical-stage neuroscience biotech transforming the treatment paradigm of psychiatric diseases.
Reimagines psychoactive natural products as the building blocks for the next generation of neurological products
AIVITA Biomedical is a biotechnology company developing personalized vaccines that target multiple pathogens and tumor-initiating cells—the seed of all cancers—using our autologous personal immunotherapy platform.
An award-winning breakthrough wellness platform
Immunis is a clinical-stage biotech company developing multi-active biologics with immune modulating factors that can address age-related diseases and immune dysregulation.
Light Alliance Summit: Cuba 2026 - An Immersive Journey into Conscious Community & Collective Impact
March 19-22, 2026
Simeon will be speaking at the second annual Light Alliance Summit—an inspiring gathering of global visionaries, conscious leaders, entrepreneurs, investors, and creators committed to co-creating a future defined by abundance, wellness, and meaningful connection.
Billion dollar deal shakes up the neuroscience industry. GH Research and Compass Pathways receive FDA consent to advance clinical trials.
Check Out Our Substack!
.png){kind=small}
